| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 10/01/2002 | CA2145411C Viscous liquid xylitol compositions and process for preparing the same |
| 10/01/2002 | CA2081911C Method and composition for treating psoriasis |
| 09/26/2002 | WO2002074348A1 Dry powder compositions comprising labelled particles for inhalation |
| 09/26/2002 | WO2002074289A2 Antitumor compositions containing taxane derivatives |
| 09/26/2002 | WO2002074275A2 Systems for delivering a cosmetic and/or therapeutic active to oral surfaces |
| 09/26/2002 | WO2002074232A2 Antitumor compositions containing taxane derivatives |
| 09/26/2002 | WO2002062356A3 Monovalent-selective cation exchangers as oral sorbent therapy |
| 09/26/2002 | WO2002056755A3 Method for treating cancer |
| 09/26/2002 | WO2002026277A3 Stabilized hydrogen peroxide solutions |
| 09/26/2002 | WO2002022769A3 Method for producing a talkos silicate |
| 09/26/2002 | US20020137797 Alpha-Difluoromethylornithine (DFMO) suppresses polyamine levels in the human prostate |
| 09/26/2002 | US20020137761 Treating tolerance or drug addiction; analgesics |
| 09/26/2002 | US20020137749 Formulation for menopausal women |
| 09/26/2002 | US20020137732 Small molecule inhibitors targeted at Bcl-2 |
| 09/26/2002 | US20020137722 Method for treating a patient with neoplasia by treatment with a paclitaxel derivative |
| 09/26/2002 | US20020137691 Supplement collagen and elastic tissues and thicken the dermis; administering a sugar compound converting mucopoly-saccharides; enzyme inhibitor of collangenase/elastase; an amino acid; fat burner, vaso-dilator and chromium picolinate |
| 09/26/2002 | US20020136934 Glass-, ceramic- or vitroceramic-based substrate with a coating of partially crystalline titanium dioxide; self-cleaning glazings for vehicles or buildings |
| 09/26/2002 | US20020136758 Patch for transdermal therapy |
| 09/26/2002 | US20020136750 Acidified nitrite as an antimicrobial agent |
| 09/26/2002 | US20020134691 Electrolyzing water containing a reducing agent to give reducing electrolyzed water having a pH of 3 to 12 and an oxidation-reduction polential up to -200 mV |
| 09/25/2002 | EP1242119A2 Combinations for the treatment of dna viral infections comprising a loop diuretic and a cardiac glycoside |
| 09/25/2002 | EP1242110A1 A method and composition for treating prostate cancer |
| 09/25/2002 | EP1242098A2 Aqueous ionic solutions and their uses in particular in ophthalmology |
| 09/25/2002 | EP1242097A2 Pharmaceutical composition comprising a vanadium compound and at least a component selected from a na+/h+ exchanger, cyclo-oxygenase inhibitors and caspase inhibitors |
| 09/25/2002 | EP1242096A2 Combinations for the treatment of dna viral infections comprising a loop diuretic and lithium |
| 09/25/2002 | EP1242073A2 Compositions for prevention and treatment of cold and influenza-like symptoms and their methods of use |
| 09/25/2002 | CN1371388A Hexapeptide with stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation differentiation and apoptosis |
| 09/25/2002 | CN1371291A Method and formula for tumor remission and suppression of cancer |
| 09/25/2002 | CN1371288A Method for preparing polycation based bioconjugates suitable for transporting different kinds of active substances within the body |
| 09/25/2002 | CN1371286A Use of cyclooxygenase-2 inhibitor matrix metallappoteinase inhibitor antineoplastic agent and optionally radiation as combination treatment of neoplasia |
| 09/25/2002 | CN1371278A Pharmaceutically stable oxaliplatinum preparation for parenteral administration |
| 09/25/2002 | CN1370585A Composite Chinese medicine prepn for treating type II diabetes |
| 09/25/2002 | CN1370557A Ulcer treating capsule and its prepn |
| 09/25/2002 | CN1370553A Brain-invigorating tic-stopping medicine and its prepn |
| 09/25/2002 | CN1370540A Medicine for treating maligant leucoma and its compounding process |
| 09/25/2002 | CN1091383C Process for powdered medicine from natural plant medicated bath liquid |
| 09/25/2002 | CN1091379C Detoxicating instant particles and preparing method thereof |
| 09/25/2002 | CN1091375C Nucleic acid hypoglycemic mixture |
| 09/25/2002 | CN1091374C External medicine for treating sore caused by shell wound or bullet wound |
| 09/25/2002 | CN1091373C Use of calomelas in pharmacy |
| 09/24/2002 | US6455076 Formulations and methods for reducing skin irritation |
| 09/24/2002 | US6455061 Mixture containing n-acetylcysteine, lysine hydrochloride, 2-amino-2-deoxyglucose and magnesium compound |
| 09/19/2002 | WO2002072112A1 Use of selenite or preparations containing selenite for treating wounds |
| 09/19/2002 | WO2002072091A1 Anticancer drug-tolerance inhibitors |
| 09/19/2002 | WO2002072085A1 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases |
| 09/19/2002 | WO2002072041A1 Cosmetics and treatment method for promoting maturation of cornified envelopes |
| 09/19/2002 | WO2002072010A2 Taxane prodrugs |
| 09/19/2002 | WO2002048154A3 Cobalt-porphyrin complexes and use thereof as an anti-obesity agent |
| 09/19/2002 | WO2001093858A3 Use of an aluminium and ethylenediamine-tetraacetic complex for preventing and/or treating urticaria |
| 09/19/2002 | US20020132795 Methods for treatment of neuro- and nephro- disorders and therapeutic toxicities using aminothiol compounds |
| 09/19/2002 | US20020132781 Optionally a glutathione pathway enhancing and detoxifying compound, particularly cystine |
| 09/19/2002 | US20020132219 Composition and method for modulating nutrient partitioning |
| 09/19/2002 | US20020132030 Edible microbiocide of .05-1.0% alkyl paraben, and .1-.2% benzoic and sorbic acids salts |
| 09/19/2002 | US20020132015 Compositions and methods for high sorption of skin materials and delivery of sulfur |
| 09/19/2002 | US20020131998 Rapidly dissolving dosage form and process for making same |
| 09/19/2002 | CA2440555A1 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases |
| 09/19/2002 | CA2440225A1 Taxane prodrugs |
| 09/19/2002 | CA2438164A1 Use of preparations containing selenite or selenate |
| 09/18/2002 | EP0910388B1 Pharmaceutical preparation for the treatment of gastritis, reflux oesophagitis, duodenitis, dyspepsia and ulcer disease |
| 09/18/2002 | EP0759765B1 Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof |
| 09/18/2002 | CN1370201A Polymeric compsn. for solubilizing poorly water soluble drugs and process for prepn. thereof |
| 09/18/2002 | CN1370084A Tissue augmentation material and methods |
| 09/18/2002 | CN1370082A Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies |
| 09/18/2002 | CN1369711A Reagent for diagnosing oral diseases |
| 09/18/2002 | CN1369308A Liniment 'Rubikang' and its preparing process |
| 09/18/2002 | CN1369294A Liniment for repairing scratched face without residual scar |
| 09/18/2002 | CN1369283A Eye drops containing bio-active catalytic enzyme |
| 09/18/2002 | CN1369269A Nano silver antibacterial film for women its preparing method and use |
| 09/18/2002 | CN1369268A Application of iodophores in preparing medicine |
| 09/18/2002 | CN1369214A Universal detoxicant |
| 09/18/2002 | CN1369206A Nano Silver sterilizing gel, its preparing method and use |
| 09/18/2002 | CN1090960C Process for preparing onychomycosis liquid |
| 09/18/2002 | CN1090956C Tibetan pill for treating cholecytitis and gallstones, and method for preparing same |
| 09/18/2002 | CN1090953C Prepn. and use of external-use medicine for cardiac and cerebral vascular diseases and rhematism |
| 09/18/2002 | CN1090950C Combined Chinese and western medicine for treating nevus and its prepn.method |
| 09/18/2002 | CN1090946C Health medicine for tonifying spleen and removing dampness heat |
| 09/18/2002 | CN1090945C Bone setting capsle and its preparing process |
| 09/18/2002 | CN1090942C Compound phosphate liquor for curing cystic tumor and angioma |
| 09/18/2002 | CN1090941C Skin compsns. contg. benzoyl oxide and compound able to decrease skin stimulation |
| 09/18/2002 | CN1090940C Medicinal powder for treating burn and scald |
| 09/18/2002 | CN1090939C Calcim iron concentration liquid and process for producing same |
| 09/17/2002 | US6451746 Cleaning compounds comprising a liquid ingredient in an amount of <50% by weight of the compound and expanded anhydrous sodium perborate; stability, dissolution, hardness and tablet production; receptivity |
| 09/17/2002 | US6451358 Composition and method for the treatment of vitiligo |
| 09/17/2002 | US6451354 Natural product composition for decreasing IgE production and treating secondary allergic responses |
| 09/17/2002 | US6451352 Adminsitering sea water as antiinflammatory agent to mucous membranes of the respiratory tract |
| 09/17/2002 | US6451328 Free radical scavenger for skin; aging resistance; cancer prevention; cosmetics; electropositivity, electronegativity |
| 09/12/2002 | WO2002070027A1 Medical preparation that promotes acceptance of a graft |
| 09/12/2002 | WO2002070008A1 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist |
| 09/12/2002 | WO2002070000A1 Recombinant gelatin-like proteins for use as plasma expanders |
| 09/12/2002 | WO2002069985A2 Immune response potentiation |
| 09/12/2002 | WO2002069955A1 Method and formula for anti-tumor and anti-matastatic effect |
| 09/12/2002 | WO2002069887A2 Virucidal compositions |
| 09/12/2002 | WO2002047703A3 Immune system stimulation |
| 09/12/2002 | WO2002017735A3 Method for preparing a mixture that can be granulated and carnitine-magnesium hydroxycitrate |
| 09/12/2002 | WO2001091770A3 Compositions for treating eye discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins |
| 09/12/2002 | WO2001091768A3 Compositions for treating brain disorders and enhancing brain function, containing herbals and/or nutritional supplements and/or minerals and/or vitamins |
| 09/12/2002 | WO2001091741A3 Compositions containing hexitol and an antiproliferative agent |
| 09/12/2002 | WO2001012247A9 Tissue augmentation material and method |
| 09/12/2002 | US20020128273 Composition and method for treating the effects of diseases and maladies |
| 09/12/2002 | US20020128257 2-benzazipine derivative; antineoplastic, antitumor, antiinflammatory and antimetastasis agents |